Jack Quaid’s action-comedy “Novocaine” topped a painfully slow weekend at the box office with $8.7 million. For theater owners, however, there’s not too much to celebrate: It’s one of the worst debuts to still capture the No.

Novocaine, the new action thriller starring Star Trek and The Boys alum, Jack Quaid, hasn't earned back its production budget at the box office yet.

Quaid's leading role in Novocaine feels like a natural continuation of these genre-bent everymen. He plays Nathan Caine, a mild-mannered assistant bank manager who has congenital insensitivity to pain with anhidrosis (CIPA), a genetic disorder that impacts his nervous system to the point that he can't feel pain or temperature.

Movie theaters haven’t exactly been bustling since the start of 2025 and the calendar year is about to turn in one of its most meagre frames yet. Even with two new wide releases - Paramount’s slapstick actioner “Novocaine” and Focus Features’ spy film “Black Bag” - exhibitors are in danger of a particularly beleaguered weekend,

Writethru: Thank God for Snow White next weekend, right? Who knew with that movie’s controversy we’d be saying that!? However, the industry should be thankful: If Snow White pulls off a $50 million-plus opening,

A mid-March weekend at the box office is supposed to be a busy one with spring break beginning and four-quadrant films on offer. But the film industry is in such a terrible slump that Paramount's R-rated action comedy "Novocaine" was able to take No.

Though Novocaine, Quaid’s new superhero-ish film, is currently leading the weekend box office, that's not as impressive an achievement as it might sound. According to Deadline, the film has only managed to take in a rather unimpressive $8.